Sirna Therapeutics said this week that it has formed a sponsored-research collaboration with Massachusetts General Hospital researcher Zheng-Yi Chen to support his work into using RNA interference to restore hearing loss.

Chen's research focuses on the gene expressing retinoblastoma protein, pRb. According to Chen, this gene has been found to play a role in the production of hair cells in the inner ear, which convert sound into neural impulses.